---
figid: PMC4185425__nihms620406f3
figtitle: 'The Programmed Death-1 Immune Suppressive Pathway: Barrier to Anti-Tumor
  Immunity'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC4185425
filename: nihms620406f3.jpg
figlink: /pmc/articles/PMC4185425/figure/F3/
number: F3
caption: Soluble CD80 may (i) prevent PD-L1+ cells (tumor cells, lymphoid cells, or
  other PD-L1+ cells) from anergizing PD-1+ activated T cells; (ii) prevent PD-L1+
  cells from anergizing CD80+ T cells by reverse signaling through T cell-expressed
  CD80; and (iii) enhance T cell activation by costimulating tumor antigen-specific
  T cells through CD28.
papertitle: 'The Programmed Death-1 Immune Suppressive Pathway: Barrier to Anti-Tumor
  Immunity.'
reftext: Suzanne Ostrand-Rosenberg, et al. J Immunol. ;193(8):3835-3841.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9763529
figid_alias: PMC4185425__F3
figtype: Figure
redirect_from: /figures/PMC4185425__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4185425__nihms620406f3.html
  '@type': Dataset
  description: Soluble CD80 may (i) prevent PD-L1+ cells (tumor cells, lymphoid cells,
    or other PD-L1+ cells) from anergizing PD-1+ activated T cells; (ii) prevent PD-L1+
    cells from anergizing CD80+ T cells by reverse signaling through T cell-expressed
    CD80; and (iii) enhance T cell activation by costimulating tumor antigen-specific
    T cells through CD28.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - APC
  - PROC
  - CD274
  - CD80
  - CD28
  - CTLA4
  - PDCD1
  - RPL17
  - RPL17-C18orf32
---
